Search

Search Constraints

You searched for: Author/Creator Ibrahim, N

Search Results

1. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. (31st January 2019)

2. 1244OKEYNOTE-022 Part 3: Phase II randomized study of 1L dabrafenib (D) and trametinib (T) plus pembrolizumab (Pembro) or placebo (PBO) for BRAF-mutant advanced melanoma. (23rd October 2018)

3. 1278PHealth-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial. (23rd October 2018)

4. PMO-151 Excellent disease free and overall survival rates after long term follow-up of a cohort of injecting drug users treated for HCV. (28th May 2012)

6. EP592 HE4 has a role in identifying high risk prognostic factors in endometrial cancer. (1st November 2019)